Trial intelligence / Profile preview

INFUSE-TM: Hylenex-facilitated SC Rehydration vs ORT

NCT01120431Phase 4Withdrawn

Sponsor
Baxter
Start
May 2010
Primary completion
May 2010
Modality
Therapeutic Enzymes
01

Overview

A Phase 4 trial of hyaluronidase in dehydration, sponsored by Baxter. Planned start May 2010; status: withdrawn.

02

Drugs

hyaluronidase
03

Conditions

dehydration

Beyond the preview

Go deeper on NCT01120431.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01120431.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call